CMO Moves: Regulatory catalysts for therapy manufacturing -January
January 16th, 2023 | 🕒
https://www.ispeech.org In the first 2023 edition of the CMO Moves monthly series, Pharmaceutical Technology explores recent news stories on regulatory
January 16th, 2023 | 🕒
https://www.ispeech.org In the first 2023 edition of the CMO Moves monthly series, Pharmaceutical Technology explores recent news stories on regulatory
December 12th, 2022 | 🕒
iSpeech In this last 2022 edition of the series, which started in June, Pharmaceutical Technology is tracking major trial announcements
November 30th, 2022 | 🕒
iSpeech Decisions by the UK’s NICE for select therapies from late September to October and the CMOs contracted to manufacture
October 15th, 2022 | 🕒
https://www.ispeech.org PARIS--(BUSINESS WIRE)--Technip Energies (Paris:TE) (ISIN:NL0014559478) and Shell Catalysts & Technologies are building on their successful track record of collaboration
August 19th, 2022 | 🕒
Convert Text to Speech Pharmaceutical and biotech companies live and die by regulatory decisions on their therapies. These verdicts not
June 1st, 2022 | 🕒
https://www.ispeech.org As regulatory decisions to influence a drug’s future on the market trickle in, companies have already set in motion
March 30th, 2022 | 🕒
iSpeechMorgan Stanley downgrades NortonLifeLock, sees 'limited catalysts' for the cybersecurity company CNBC Source link
December 19th, 2021 | 🕒
Powered by iSpeech Oregon State University research into the design of catalysts has shown that hydrogen can be cleanly produced
December 11th, 2021 | 🕒
Text to Speech Voices Mumbai: LegalPay, a tech-based alternative-investments platform specialising in legal financing investments, raised an undisclosed pre-series A
May 25th, 2021 | 🕒
iSpeech.org BEDFORD, Mass.--(BUSINESS WIRE)--Aspen Technology, Inc. (NASDAQ:AZPN), a global leader in asset optimization software, today announced that Shell Catalysts &
Gloss